HomeMNPR • NASDAQ
add
Monopar Therapeutics Inc
Previous close
$38.02
Day range
$37.10 - $39.43
Year range
$1.72 - $54.10
Market cap
226.94M USD
Avg Volume
21.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.22M | 86.95% |
Net income | -2.62M | -59.94% |
Net profit margin | — | — |
Earnings per share | -0.38 | 24.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 54.55M | 520.39% |
Total assets | 55.09M | 518.08% |
Total liabilities | 1.49M | 3.96% |
Total equity | 53.59M | — |
Shares outstanding | 6.12M | — |
Price to book | 4.34 | — |
Return on assets | -13.96% | — |
Return on capital | -14.83% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.62M | -59.94% |
Cash from operations | -5.66M | -242.11% |
Cash from investing | -325.83K | 66.86% |
Cash from financing | -115.68K | -103.64% |
Net change in cash | -6.10M | -1,227.40% |
Free cash flow | -4.87M | -333.18% |
About
Founded
2014
Headquarters
Website
Employees
16
